...
首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Cell- and size-specific analysis of placental extracellular vesicles in maternal plasma and pre-eclampsia
【24h】

Cell- and size-specific analysis of placental extracellular vesicles in maternal plasma and pre-eclampsia

机译:胎儿血浆胎盘细胞外囊细胞和尺寸特异性分析和预普利普拉姆

获取原文
获取原文并翻译 | 示例
           

摘要

Despite decades of investigation, we cannot predict, prevent, or adequately treat the most common and deadly complications of pregnancy, including pre-eclampsia (pregnancy-induced hypertension). The current working hypothesis for the repeated failures of several multicenter studies that measured a wide variety of biomarkers is common pregnancy complications like pre-eclampsia are most likely heterogeneous syndromes with various etiologies; therefore, no combination of blood-based biomarkers will provide predictive power. Although the clinical syndrome of pre-eclampsia may have various causes, the current dogma is most cases share similar placental pathology, including accelerated chorionic villous maturation and an increased frequency of malperfusion-related infarctions. This pathology is thought to begin in the late first trimester of pregnancy. The challenge has been to develop an approach to monitor placental healthin vivo. New contrast-enhanced imaging studies of blood flow to the placenta are providing insights, but rapid liquid-based assays using maternal blood would be more cost-effective. Recently, there has been a growing interest in placental extracellular vesicles (EVs) to determine if these complex lipid-based spheres involved in intercellular communication offer clues to the early pathophysiology of placental damage. Most EVs are nanoscale-sized exosomes (~60–120 nm) that retain cell-specific plasma membrane surface markers. Their concentration, composition, and relative size distribution may provide clinical predictive power, but more investigation is needed. A major obstacle to advancement in this field has been the lack of EV imaging and isolation assays that can provide both cell- and size-specificity. Nanoscale multiplex high-resolution flow cytometry being developed in a number of laboratories may provide a solution. It is a potential means to quantitate both cell- and size-specific EVs from various cell sources, including the placenta.
机译:尽管有数十年的调查,我们无法预测,预防或充分治疗怀孕的最常见和致命的并发症,包括预痫前血症(妊娠诱导的高血压)。目前的工作假设对于几种多中心研究的重复失败,测量各种生物标志物是常见的妊娠并发症,如先兆子痫,最有可能具有各种病因的异质综合症;因此,没有血液的生物标志物组合将提供预测的力量。虽然预普利克萨里亚人的临床综合征可能具有各种原因,但目前的教条是大多数情况份额相似的胎盘病理,包括加速的绒毛膜绒毛成熟和患有抗性相关的紊乱的增加的频率。这种病理学被认为开始于怀孕的第一个妊娠晚期。挑战是制定一种监测胎盘健康体内的方法。新的对比增强对胎盘的血流成像研究正在提供见解,但使用母体血液的快速液体测定将更具成本效益。最近,对胎盘细胞外囊泡(EVS)的兴趣日益增长,以确定是否参与细胞间通信的基于复杂的基于脂质的球体,为胎盘损伤的早期病理生理学提供线索。大多数EV是纳米尺寸的外来肌瘤(〜60-120nm),可保持特异性细胞的血浆膜表面标记物。它们的浓度,组成和相对尺寸分布可以提供临床预测力,但需要更多的调查。该领域进步的主要障碍是缺乏EV成像和分离测定,可提供细胞和尺寸特异性。在许多实验室中开发的纳米级多重高分辨率流式细胞仪可以提供溶液。它是定量来自各种细胞源的细胞和尺寸特异性EV,包括胎盘的潜在手段。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号